BNP Paribas Asset Management
ABMD

BNP Paribas Asset Management’s Abiomed Inc ABMD Stock Holding History

BNP Paribas Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-63,704
Closed -$15.7M – 933
2022
Q3 		$15.7M Buy
63,704
+1,425
+2% +$385K 0.06% 330
2022
Q2 		$15.4M Buy
62,279
+8,186
+15% +$2.21M 0.06% 323
2022
Q1 		$17.9M Buy
54,093
+12,485
+30% +$3.84M 0.06% 318
2021
Q4 		$14.9M Buy
41,608
+20,501
+97% +$6.93M 0.05% 370
2021
Q3 		$6.87M Buy
21,107
+136
+0.6% +$46.1K 0.03% 483
2021
Q2 		$6.54M Sell
20,971
-2,284
-10% -$701K 0.02% 509
2021
Q1 		$7.41M Buy
23,255
+194
+0.8% +$62.1K 0.03% 459
2020
Q4 		$7.48M Buy
23,061
+3,040
+15% +$841K 0.03% 431
2020
Q3 		$5.55M Buy
20,021
+2,772
+16% +$799K 0.03% 417
2020
Q2 		$4.17M Buy
17,249
+2,879
+20% +$578K 0.03% 464
2020
Q1 		$2.09M Buy
14,370
+1,085
+8% +$180K 0.02% 537
2019
Q4 		$2.27M Buy
13,285
+10,778
+430% +$2M 0.02% 579
2019
Q3 		$446K Sell
2,507
-28,591
-92% -$6.18M ﹤0.01% 749
2019
Q2 		$8.1M Buy
31,098
+2,856
+10% +$758K 0.07% 338
2019
Q1 		$8.06M Buy
28,242
+19,009
+206% +$6.32M 0.07% 344
2018
Q4 		$2.94M Sell
9,233
-6,391
-41% -$2.22M 0.03% 541
2018
Q3 		$7.03M Buy
15,624
+5,799
+59% +$2.29M 0.05% 414
2018
Q2 		$4.02M Sell
9,825
-28,366
-74% -$10.3M 0.03% 522
2018
Q1 		$11.1M Sell
38,191
-20,859
-35% -$5.29M 0.09% 304
2017
Q4 		$11.1M Sell
59,050
-71,302
-55% -$13.3M 0.09% 314
2017
Q3 		$22M Sell
130,352
-10,902
-8% -$1.65M 0.19% 138
2017
Q2 		$20.2M Sell
141,254
-223
-0.2% -$30K 0.18% 131
2017
Q1 		$17.7M Buy
141,477
+15,221
+12% +$1.76M 0.16% 155
2016
Q4 		$14.2M Buy
126,256
+38,866
+44% +$4.5M 0.14% 195
2016
Q3 		$11.2M Sell
87,390
-37,816
-30% -$4.53M 0.1% 286
2016
Q2 		$13.7M Sell
125,206
-19,705
-14% -$1.96M 0.12% 239
2016
Q1 		$13.7M Sell
144,911
-15,023
-9% -$1.27M 0.12% 243
2015
Q4 		$14.4M Buy
159,934
+9,885
+7% +$839K 0.12% 222
2015
Q3 		$13.9M Sell
150,049
-47,005
-24% -$4.14M 0.12% 242
2015
Q2 		$13M Buy
197,054
+4,849
+3% +$322K 0.1% 271
2015
Q1 		$13.8M Buy
192,205
+91,929
+92% +$4.99M 0.11% 271
2014
Q4 		$3.82M Buy
+100,276
New +$3.16M 0.03% 490

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BNP Paribas Asset Management's ABMD Position: Q4 2022 in Review

BNP Paribas Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 63,704 shares — an estimated $15.7M sold.

BNP Paribas Asset Management first reported a position in ABMD in Q4 2014 and held it in 32 quarters. The position peaked at $22M in Q3 2017. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • BNP Paribas Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Asset Management sold 63,704 Abiomed Inc shares in Q4 2022, an estimated $15.7M.
  • BNP Paribas Asset Management first reported a position in Abiomed Inc in Q4 2014 and held it in 32 quarters.
  • BNP Paribas Asset Management's Abiomed Inc position peaked at $22M in Q3 2017.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on BNP Paribas Asset Management's 13F filing for Q4 2022, filed 10 Feb 2023.